56 related articles for article (PubMed ID: 24931370)
1. miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes glioma growth.
Yan Z; Wang J; Wang C; Jiao Y; Qi W; Che S
FEBS Lett; 2014 Aug; 588(17):3038-46. PubMed ID: 24931370
[TBL] [Abstract][Full Text] [Related]
2. Exploring signaling pathway crosstalk in glioma by mapping miRNA and WNT pathways: A review.
Isa AI
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128722. PubMed ID: 38092099
[TBL] [Abstract][Full Text] [Related]
3. Aflatoxin B1 negatively regulates Wnt/β-catenin signaling pathway through activating miR-33a.
Fang Y; Feng Y; Wu T; Srinivas S; Yang W; Fan J; Yang C; Wang S
PLoS One; 2013; 8(8):e73004. PubMed ID: 24015284
[TBL] [Abstract][Full Text] [Related]
4. Significant Genes Associated with Mortality and Disease Progression in Grade II and III Glioma.
Choi BM; Cheong JH; Ryu JI; Won YD; Min KW; Han MH
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672212
[TBL] [Abstract][Full Text] [Related]
5. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.
Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X
J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219
[TBL] [Abstract][Full Text] [Related]
6. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
Lee MF; Hsieh NT; Huang CY; Li CI
J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
[TBL] [Abstract][Full Text] [Related]
7.
Carvalho BF; Gomez GVB; Carron J; Macedo LT; Gonçalves GM; Vazquez VL; Serrano SV; Lourenço GJ; Lima CSP
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474115
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-96: A therapeutic and diagnostic tumor marker.
Rahimi HR; Mojarrad M; Moghbeli M
Iran J Basic Med Sci; 2022 Jan; 25(1):3-13. PubMed ID: 35656454
[TBL] [Abstract][Full Text] [Related]
9. The miR-183/96/182 cluster is upregulated in glioblastoma carrying EGFR amplification.
Schneider B; William D; Lamp N; Zimpfer A; Henker C; Classen CF; Erbersdobler A
Mol Cell Biochem; 2022 Sep; 477(9):2297-2307. PubMed ID: 35486213
[TBL] [Abstract][Full Text] [Related]
10. miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia.
Wei Y; Lu W; Yu Y; Zhai Y; Guo H; Yang S; Zhao C; Zhang Y; Liu J; Liu Y; Fei J; Shi J
Oncogene; 2021 May; 40(19):3434-3448. PubMed ID: 33888868
[TBL] [Abstract][Full Text] [Related]
11. Reduced Expression of hsa-miR-338-3p Contributes to the Development of Glioma Cells by Targeting Mitochondrial 3-Oxoacyl-ACP Synthase (OXSM) in Glioblastoma (GBM).
Wang WY; Lu WC
Onco Targets Ther; 2020; 13():9513-9523. PubMed ID: 33061435
[TBL] [Abstract][Full Text] [Related]
12. Molecular Screening for Nigericin Treatment in Pancreatic Cancer by High-Throughput RNA Sequencing.
Xu Z; Gao G; Liu F; Han Y; Dai C; Wang S; Wei G; Kuang Y; Wan D; Zhi Q; Xu Y
Front Oncol; 2020; 10():1282. PubMed ID: 32850392
[No Abstract] [Full Text] [Related]
13. Identification of KIF15 as a potential therapeutic target and prognostic factor for glioma.
Wang Q; Han B; Huang W; Qi C; Liu F
Oncol Rep; 2020 Apr; 43(4):1035-1044. PubMed ID: 32323839
[TBL] [Abstract][Full Text] [Related]
14. β-catenin regulates effects of miR-24 on the viability and autophagy of glioma cells.
Chen H; Lu Q; Chen C; Di Y; Li Y; Min W; Yu Z; Dai D
Exp Ther Med; 2019 Aug; 18(2):1285-1290. PubMed ID: 31316620
[TBL] [Abstract][Full Text] [Related]
15. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
Liu B; Zhang J; Yang D
J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway.
Zong Z; Song Y; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Cao S; Li Z; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):5048-5062. PubMed ID: 31207033
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics.
Miroshnichenko S; Patutina O
Front Pharmacol; 2019; 10():488. PubMed ID: 31156429
[TBL] [Abstract][Full Text] [Related]
18. The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways.
Bollaert E; de Rocca Serra A; Demoulin JB
Cell Mol Life Sci; 2019 Apr; 76(8):1529-1539. PubMed ID: 30683982
[TBL] [Abstract][Full Text] [Related]
19. ZBTB7/miR-137 Autoregulatory Circuit Promotes the Progression of Renal Carcinoma.
Wang L; Li Q; Ye Z; Qiao B
Oncol Res; 2019 Sep; 27(9):1007-1014. PubMed ID: 29673422
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
